Source: https://pharmaguidances.com/technical-report-series-trs-biologicals/
Timestamp: 2020-08-09 20:33:28
Document Index: 669064383

Matched Legal Cases: ['art 1', 'art 2', 'art 1', 'art 2', 'art 1', 'art 2', 'art 1', 'art 2', 'art 1', 'art 2']

Technical Report Series (TRS) Biologicals - Pharmaceutical Guidance
Home / Audit and Guideline / Technical Report Series (TRS) Biologicals
Pharmaceutical Guidanace April 18, 2019	Audit and Guideline, Link For Guideline Comments Off on Technical Report Series (TRS) Biologicals 448 Views
68th report: TRS 1011: 2017
67th report: TRS 1004: 2016
66th report: TRS 999: 2015
65th report: TRS 993: 2014
64th report: TRS 987: 2013
63rd report: TRS 980: 2012
62nd report: TRS 979: 2011
61st report: TRS 978: 2010
60th report: TRS 977: 2009
59th report: TRS 964: 2008
58th report: TRS 963: 2007
57th report: TRS 962: 2006
56th report: TRS 941: 2005
55th report: TRS 932: 2004 [pdf 786kb]
54th report: TRs 927: 2003 [pdf 945kb]
53rd report: TRS 926: 2003 [pdf 320kb]
52nd report: TRS 924: 2001 [pdf 1.5MB]
51st report: TRS 910: 2000 [pdf 530kb]
50th report: TRS 904: 1999 [pdf 4.5MB]
49th report: TRS 897: 1998 [pdf 4.6MB]
48th report: TRS 889: 1997 [pdf 5.3MB]
47th report: TRS 878: 1996 [pdf 5.2MB]
46th report: TRS 872: 1995 [pdf 4.8MB]
45th report: TRS 858: 1994 [pdf 4.5MB]
44th report: TRS 848: 1993 [pdf 3.8MB]
43rd report:TRS 840:1992 [pdf 10MB]
42nd report: TRS 822: 1991 [pdf 3.8MB]
41st report: TRS 814: 1990 [pdf 3.6MB]
40th report: TRS 800: 1989 – Part 1 [pdf 3MB]
40th report: TRS 800: 1989 – Part 2 [pdf 4.6MB]
39th report: TRS 786: 1988 [pdf 6.8MB]
38th report: TRS 771: 1987 – Part 1 [pdf 3.8MB]
38th report: TRS 771: 1987 – Part 2 [pdf 4.6MB]
37th report: TRS 760: 1986 – Part 1 [pdf 4.4MB]
37th report: TRS 760: 1986 – Part 2 [pdf 3.3MB]
36th report: TRS 745: 1985 [pdf 4.9MB]
35th report: TRS 725: 1984 [pdf 5.2MB]
34th report: TRS 700: 1983 [pdf 2.8MB]
33rd report: TRS 687: 1982 [pdf 6.7MB]
32nd report: TRS 673: 1981 [pdf 6.4MB]
31st report: TRS 658: 1980 – Part 1 [pdf 5.5MB]
31st report: TRS 658: 1980 – Part 2 [pdf 5.3MB]
30th report: TRS 638: 1978 [pdf 6.4MB]
29th report: TRS 626: 1977 [pdf 5.6MB]
28th report: TRS 610: 1976 [pdf 4.9MB]
27th report: TRS 594: 1975 [pdf 3MB]
26th report: TRS 565: 1974 [pdf 3.3MB]
25th report: TRS 530: 1973 [pdf 2.7MB]
24th report: TRS 486 1971 [pdf 3.2MB]
23rd report: TRS 463: 1970 [pdf 4.7MB]
22nd report: TRS 444: 1969 [pdf 5.3MB]
21st report: TRS 413: 1968 [pdf 3.7MB]
20th report: TRS 384: 1967 [pdf 3.4MB]
19th report: TRS 361: 1966 [pdf 4.2MB]
18th report: TRS 329: 1965 – Part 1 [pdf 2.6MB]
18th report: TRS 329: 1965 – Part 2 [pdf 2.1MB]
17th report: TRS 293: 1964 [pdf 3MB]
16th report: TRS 274: 1963 [pdf 3.3MB]
15th report: TRS 259: 1962 [pdf 2MB]
14th report: TRS 222: 1960 [pdf 1.7MB]
13th report: TRS 187 1959 [pdf 1.5MB]
12th report: TRS 172: 1958 [pdf 1.3MB]
11th report: TRS 147: 1957 [pdf 1.2MB]
10th report: TRS 127: 1956 [pdf 1.1MB]
9th report: TRS 108: 1955 [pdf 661kb]
8th report: TRS 96: 1954 [pdf 685kb]
7th report: TRS 86: 1953 [pdf 890kb]
6th report: TRS 68: 1952 [pdf 1.05MB]
5th report: TRS 56: 1951 [pdf 879kb]
4th report: TRS 3: 1949 [pdf 395kb]
3rd report: TRS 2: 1949 [pdf 724kb]
Thank you for visit and for more pharma updates click here – https://pharmaguidances.com
Previous ANALYTICAL METHOD VALIDATION
Next Types of Audit in Pharma company
STABILITY TESTING OF NEW DRUG SUBSTANCES Q1A(R2) COVER NOTE FOR REVISION OF Q1A(R) The changes …